Corporate Responsibility

Novartis releases 2014 Corporate Responsibility Performance Report

June 24, 2015 - Novartis has a strong history of CR activities, and transparent reporting is a central part of our commitment to corporate responsibility. We have publicly reported on our performance in this area since 2000 through our Annual Report and several online and printed materials.

The 2014 CR Performance Report aims to meet the needs and expectations of CR professional audiences by offering easy access to key data. The report also details progress against Novartis priorities, defined following a CR materiality process.

In response to feedback received from stakeholders on the company’s 2013 CR Performance Report, the 2014 CR Performance Report offers additional historical data and further consolidation of CR information, as well as an enhanced narrative to provide context for Novartis CR reporting.

The report reflects the best-in-class reporting standard, the Global Reporting Initiative’s (GRI) G4 guidelines. The GRI’s fourth generation of CR reporting guidelines were launched in May 2013. They emphasize the need for companies to focus on the process of identifying topics that are material for corporate responsibility in their specific business and among their key stakeholders.

You can review 2014 CR achievement highlights, including Sandoz projects, or download the report for yourself, by visiting Novartis.com.

 

history_timeline_2014_05

Sandoz History

A journey into the historical roots of our company. Explore the Sandoz history